Black Rock Inc. Nuvation Bio Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Black Rock Inc. holds 12,529,048 shares of NUVB stock, worth $38.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,529,048

Previous 12,882,429 2.74%

Holding current value

$38.1 Million

Previous $19.5 Million 134.45%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.46 - $3.97 $515,936 - $1.4 Million	-353,381 Reduced 2.74%	12,529,048 $45.6 Million
Q4 2023 Feb 13, 2024	SELL	$0.96 - $1.53 $312,211 - $497,586	-325,220 Reduced 2.46%	12,882,429 $19.5 Million
Q3 2023 Nov 13, 2023	SELL	$1.26 - $2.1 $276,853 - $461,422	-219,725 Reduced 1.64%	13,207,649 $17.7 Million
Q2 2023 Aug 11, 2023	BUY	$1.56 - $1.84 $3.48 Million - $4.1 Million	2,229,603 Added 19.91%	13,427,374 $24.2 Million
Q1 2023 May 12, 2023	BUY	$1.6 - $2.48 $321,657 - $498,569	201,036 Added 1.83%	11,197,771 $18.6 Million

Q4 2022 Feb 13, 2023	BUY	$1.68 - $2.5 $1.19 Million - $1.77 Million	709,843 Added 6.9%	10,996,735 $21.1 Million
Q3 2022 Nov 14, 2022	BUY	$0.29 - $4.04 $45,137 - $628,813	155,647 Added 1.54%	10,286,892 $23 Million
Q2 2022 Aug 12, 2022	SELL	$3.24 - $5.85 $3.63 Million - $6.56 Million	-1,120,810 Reduced 9.96%	10,131,245 $32.8 Million
Q1 2022 May 12, 2022	BUY	$4.6 - $8.83 $2.09 Million - $4.02 Million	455,021 Added 4.21%	11,252,055 $59.2 Million
Q4 2021 Feb 10, 2022	BUY	$7.75 - $10.05 $41.8 Million - $54.2 Million	5,397,329 Added 99.96%	10,797,034 $91.8 Million
Q3 2021 Nov 09, 2021	BUY	$7.78 - $10.0 $17 Million - $21.9 Million	2,186,242 Added 68.03%	5,399,705 $53.7 Million
Q2 2021 Aug 11, 2021	BUY	$9.22 - $14.48 $29.6 Million - $46.5 Million	3,213,463 New	3,213,463 $29.9 Million

Others Institutions Holding NUVB

# of Institutions

126

Shares Held

107M

Call Options Held

40.6K

Put Options Held

2.9K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $660M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account